Recruiting A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study) NCT06023862 Conditions Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +29 more Locations Monash Medical Centre — Clayton, Clayton Rd., Australia Calvary Mater Newcastle — Waratah, Edith Saint, Australia Peter MacCallum Cancer Centre — Melbourne, Grattan Saint, Australia University of Hong Kong — Hong Kong, Pok Fu Ram View all 27 locations View more locations Show fewer locations Loading locations... View Trial Details
